Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma

Clinical trial NCT01342757 · COMPLETED

Trial details

NCT number: NCT01342757
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Adult Glioblastoma Depression Recurrent Adult Brain Tumor

Start date: 2010-12-01
Primary completion: 2012-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.